rivaroxaban
Rivaroxaban, sold under the brand name Xarelto among others, is an anticoagulant medication (blood thinner) used to treat and reduce the risk of blood clots. Specifically it is used to treat deep vein thrombosis and pulmonary emboli and prevent blood clots in atrial fibrillation and following hip or knee surgery. It is taken by mouth.
Key facts
- Drug.pregnancy_AU
- C
- Drug.Verifiedfields
- changed
- Drug.verifiedrevid
- 459434616
- Drug.image
- Rivaroxaban2DCSD.svg
- Drug.image_class
- skin-invert-image
- Drug.width
- 250
- Drug.image2
- Rivaroxaban xtal 2005.png
- Drug.image_class2
- bg-transparent
- Drug.width2
- 250
- Drug.tradename
- Xarelto, others
- Drug.MedlinePlus
- a611049
- Drug.DailyMedID
- Rivaroxaban
- Drug.routes_of_administration
~12 min read
Article
13 sectionsContents
- Medical uses
- Contraindications
- Adverse effects
- Reversal agent
- Mechanism of action
- Chemistry
- History
- Society and culture
- Economics
- Legal status
- Legal action
- Research
- References
{{Infobox drug | Verifiedfields = changed | verifiedrevid = 459434616 | image = Rivaroxaban2DCSD.svg | image_class = skin-invert-image | width = 250 | alt = | image2 = Rivaroxaban xtal 2005.png | image_class2 = bg-transparent | width2 = 250 | alt2 =
| pronounce = | tradename = Xarelto, others | Drugs.com = | MedlinePlus = a611049 | DailyMedID = Rivaroxaban | pregnancy_AU = C | pregnancy_AU_comment = | pregnancy_category = | routes_of_administration = By mouth | class = | ATC_prefix = B01 | ATC_suffix = AF01 | ATC_supplemental =
Gallery (3)
Connections
Categories
2-OxazolidinonesChloroarenesDirect Xa inhibitorsDrugboxes which contain changes to verified fieldsDrugs developed by BayerDrugs developed by Johnson & JohnsonDrugs with non-standard legal statusECHA InfoCard ID from WikidataJanssen PharmaceuticaMorpholinonesThiophenesWorld Health Organization essential medicines